Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Statistics

Total Valuation

ASX:EYE has a market cap or net worth of AUD 48.42 million. The enterprise value is 46.38 million.

Market Cap	48.42M
Enterprise Value	46.38M

Important Dates

The last earnings date was Sunday, February 1, 2026.

Earnings Date	Feb 1, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:EYE has 284.82 million shares outstanding. The number of shares has increased by 21.16% in one year.

Current Share Class	284.82M
Shares Outstanding	284.82M
Shares Change (YoY)	+21.16%
Shares Change (QoQ)	+15.51%
Owned by Insiders (%)	6.75%
Owned by Institutions (%)	17.46%
Float	233.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.65
PB Ratio	2.55
P/TBV Ratio	4.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.12
EV / Sales	1.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.19

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.16.

Current Ratio	2.39
Quick Ratio	1.79
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-0.47
Interest Coverage	-56.87

Financial Efficiency

Return on equity (ROE) is -44.96% and return on invested capital (ROIC) is -53.08%.

Return on Equity (ROE)	-44.96%
Return on Assets (ROA)	-19.92%
Return on Invested Capital (ROIC)	-53.08%
Return on Capital Employed (ROCE)	-42.08%
Weighted Average Cost of Capital (WACC)	8.87%
Revenue Per Employee	97,233
Profits Per Employee	-30,096
Employee Count	301
Asset Turnover	1.04
Inventory Turnover	2.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.67% in the last 52 weeks. The beta is 0.89, so ASX:EYE's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+16.67%
50-Day Moving Average	0.15
200-Day Moving Average	0.14
Relative Strength Index (RSI)	54.38
Average Volume (20 Days)	949,707

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:EYE had revenue of AUD 29.27 million and -9.06 million in losses. Loss per share was -0.04.

Revenue	29.27M
Gross Profit	18.89M
Operating Income	-8.99M
Pretax Income	-9.06M
Net Income	-9.06M
EBITDA	-6.72M
EBIT	-8.99M
Loss Per Share	-0.04

Balance Sheet

The company has 5.06 million in cash and 3.02 million in debt, with a net cash position of 2.04 million or 0.01 per share.

Cash & Cash Equivalents	5.06M
Total Debt	3.02M
Net Cash	2.04M
Net Cash Per Share	0.01
Equity (Book Value)	18.97M
Book Value Per Share	0.07
Working Capital	7.17M

Cash Flow

In the last 12 months, operating cash flow was -6.15 million and capital expenditures -298,000, giving a free cash flow of -6.45 million.

Operating Cash Flow	-6.15M
Capital Expenditures	-298,000
Free Cash Flow	-6.45M
FCF Per Share	-0.02

Margins

Gross margin is 64.54%, with operating and profit margins of -30.70% and -30.95%.

Gross Margin	64.54%
Operating Margin	-30.70%
Pretax Margin	-30.95%
Profit Margin	-30.95%
EBITDA Margin	-22.97%
EBIT Margin	-30.70%
FCF Margin	n/a

Dividends & Yields

ASX:EYE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.16%
Shareholder Yield	-21.16%
Earnings Yield	-18.71%
FCF Yield	-13.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 10, 2001. It was a reverse split with a ratio of 0.2.

Last Split Date	Jul 10, 2001
Split Type	Reverse
Split Ratio	0.2

Scores

ASX:EYE has an Altman Z-Score of 1.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.28
Piotroski F-Score	2